NLS Pharmaceutics Ltd (NLSP)
0.1533
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 5.453M |
May 16, 2024 | 4.821M |
May 15, 2024 | 4.673M |
May 14, 2024 | 4.886M |
May 13, 2024 | 4.435M |
May 10, 2024 | 4.383M |
May 09, 2024 | 4.478M |
May 08, 2024 | 4.353M |
May 07, 2024 | 4.409M |
May 06, 2024 | 4.240M |
May 03, 2024 | 4.327M |
May 02, 2024 | 4.240M |
May 01, 2024 | 4.149M |
April 30, 2024 | 4.400M |
April 29, 2024 | 4.485M |
April 26, 2024 | 4.270M |
April 25, 2024 | 4.084M |
April 24, 2024 | 3.764M |
April 23, 2024 | 3.989M |
April 22, 2024 | 3.976M |
April 19, 2024 | 4.097M |
April 18, 2024 | 4.097M |
April 17, 2024 | 4.110M |
April 16, 2024 | 4.283M |
April 15, 2024 | 4.478M |
Date | Value |
---|---|
April 12, 2024 | 4.829M |
April 11, 2024 | 5.000M |
April 10, 2024 | 4.829M |
April 09, 2024 | 4.816M |
April 08, 2024 | 4.439M |
April 05, 2024 | 4.509M |
April 04, 2024 | 5.029M |
April 03, 2024 | 5.280M |
April 02, 2024 | 5.969M |
April 01, 2024 | 5.817M |
March 28, 2024 | 6.146M |
March 27, 2024 | 5.501M |
March 26, 2024 | 5.921M |
March 25, 2024 | 5.518M |
March 22, 2024 | 6.146M |
March 21, 2024 | 4.519M |
March 20, 2024 | 4.051M |
March 19, 2024 | 8.133M |
March 18, 2024 | 8.148M |
March 15, 2024 | 9.572M |
March 14, 2024 | 10.51M |
March 13, 2024 | 10.75M |
March 12, 2024 | 9.050M |
March 11, 2024 | 10.33M |
March 08, 2024 | 9.342M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.764M
Minimum
Apr 24 2024
70.97M
Maximum
Mar 12 2021
22.71M
Average
21.37M
Median
Oct 09 2023
Enterprise Value Benchmarks
AC Immune SA | 198.33M |
CRISPR Therapeutics AG | 2.666B |
Addex Therapeutics Ltd | 4.792M |
Molecular Partners AG | -98.31M |
MoonLake Immunotherapeutics | 1.962B |